Washington Report: PDUFA Blues - Pharmaceutical Executive


Washington Report: PDUFA Blues
The Prescription Drug User Fee Act is up for reauthorization. Let the games begin.

Pharmaceutical Executive

If the current plan succeeds in modernizing and expanding the US vaccine-production infrastructure, that may be money well spent. But industry may share the blame if it benefits from government grants but never has to respond to a real emergency.

Jill Wechsler is Pharm Exec's Washington correspondent. She can be reached at


blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here